1. Home
  2. LEDS vs SNGX Comparison

LEDS vs SNGX Comparison

Compare LEDS & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.23

Market Cap

12.2M

Sector

Technology

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.20

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEDS
SNGX
Founded
2005
1987
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
12.3M
IPO Year
2010
2006

Fundamental Metrics

Financial Performance
Metric
LEDS
SNGX
Price
$1.23
$1.20
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
10.5K
112.9K
Earning Date
04-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
53.12
N/A
EPS
N/A
N/A
Revenue
$43,009,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.11
$1.02
52 Week High
$3.37
$6.23

Technical Indicators

Market Signals
Indicator
LEDS
SNGX
Relative Strength Index (RSI) 34.53 48.83
Support Level N/A $1.19
Resistance Level $2.02 $1.22
Average True Range (ATR) 0.07 0.07
MACD -0.02 0.00
Stochastic Oscillator 26.67 43.18

Price Performance

Historical Comparison
LEDS
SNGX

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: